BASF to Acquire Shares in Alsachimie

BASF and DOMO Chemicals have signed an agreement giving BASF the right to acquire DOMO Chemicals' 49% stake in the Alsachimie joint venture, in which BASF currently holds 51%.

Aerial view of the Chalampé site
Aerial view of the Chalampé site
© BASF

Under applicable law, the proposed transaction is subject to consultations with the relevant social bodies of Alsachimie, following which both companies would enter into a binding purchase agreement. Subject to these consultations, BASF and DOMO Chemicals expect the transaction to be completed by mid-2025.

For BASF, the 100% acquisition of Alsachimie would be a strategic step to complement the company's strong presence in Chalampé, France, its European center for the production of polyamide (PA) 6.6 precursors. As sole owner of Alsachimie, BASF would be able to further strengthen the production structure and maximize the backward integration of key raw materials in the PA 6.6 value chain.

“As a key supplier for polyamide 6.6 precursors, it is our priority to ensure the reliable supply in Europe,” said Stephan Kothrade, member of the Board of Executive Directors of BASF. “By taking over the shares of our partner DOMO Chemicals, we are further strengthening our leading position and long-term commitment to the polyamide 6.6 value chain and paving the way for future growth with our customers in industries such as automotive and textiles.”

“For DOMO Chemicals, the intended transaction aligns with our strategy to continue to focus on delivering tailored polyamide solutions in the core segments automotive, consumer goods, industrial and electrical & electronics industries,” said Yves Bonte, CEO DOMO Chemicals.

Alsachimie was founded in February 2020 as a joint venture between BASF (51%) and DOMO Chemicals (49%). The company is located at the French-German border and produces essential precursors for polyamides, including KA-oil, adipic acid and hexamethylenediamine adipate (AH salt).

Company

Logo:

BASF SE

Carl-Bosch-Straße 38
67056 Ludwigshafen
Germany

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read